1st Quarter - Report
CLARK & WEINSTOCK for PHRMA
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Consumer Issues/Safety/Products CSP
Senate reauthorization of the Federal Trade Commission.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ED KUTLER | — |
| JONATHAN SCHWANTES | General Counsel, Senate Judiciary Cmte (Kohl) |
| DEIRDRE STACH New | — |
| VIN WEBER | — |
Environment/Superfund ENV
Safe and reliable drinking water.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ED KUTLER | — |
| JONATHAN SCHWANTES | General Counsel, Senate Judiciary Cmte (Kohl) |
| DEIRDRE STACH New | — |
| VIN WEBER | — |
Health Issues HCR
Importation of pharmaceuticals, noninterference and Medicare Part D.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ED KUTLER | — |
| JONATHAN SCHWANTES | General Counsel, Senate Judiciary Cmte (Kohl) |
| DEIRDRE STACH New | — |
| VIN WEBER | — |
Medicare/Medicaid MMM
Followed and lobbied in support of PhRMA's issues in legislation relating to changes in Medicare and Medicaid.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ED KUTLER | — |
| JONATHAN SCHWANTES | General Counsel, Senate Judiciary Cmte (Kohl) |
| DEIRDRE STACH New | — |
| VIN WEBER | — |
Budget/Appropriations BUD
Importation of pharmaceuticals, non-interference and Medicare Part D. Monitored budget bill for areas of interest to PhRMA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ED KUTLER | — |
| JONATHAN SCHWANTES | General Counsel, Senate Judiciary Cmte (Kohl) |
| DEIRDRE STACH New | — |
| VIN WEBER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.